Targeted screening for transthyretin cardiac amyloidosis in severe aortic stenosis: development and validation of a clinical risk score
Patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) have a relatively high prevalence prevalence of Transthyretin cardiac amyloidosis (ATTR), yet optimal screening strategies have not been clearly established. To develop and validate an easily utilized risk sc...